Clinical Application of Epiderm Growth Factor in Patients with Most Severe Eye Burns
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Ophthalmologica
- Vol. 197 (4) , 179-184
- https://doi.org/10.1159/000309941
Abstract
20 eyes of 11 patients suffering from most severe eye burns of grade 4 or worse were treated in addition to various other drugs with epiderm growth factor (EGF) or placebo in a double-blind test. Among 10 eyes treated with EGF, 6 achieved complete regeneration of the corneal epithelium, and 1 additional case, of the conjunctival epithelium. Among the eyes receiving placebo, only 3 out of 10 healed; all of them were also treated with fibronectin. Although in these very difficult cases EGF could not be investigated as a single therapy, and various other undefined factors may have been effective, in the extended course of the disease the period of EGF treatment was marked by a significant better regeneration of the epithelium.Keywords
This publication has 3 references indexed in Scilit:
- Plasmin in tear fluid of patients with corneal ulcers: basis for new therapyActa Ophthalmologica, 1987
- FibronectinArchives of Ophthalmology (1950), 1983
- The effect of the epidermal growth factor (EGF) on the corneal epithelium in humansAlbrecht von Graefes Archiv für Ophthalmologie, 1979